Antonio E. Nardi, MD, PhD

Treatment-Resistant Depression Outpatient Clinic (DeReTrat), Institute of Psychiatry, Federal University of Rio de Janeiro (IPUB-UFRJ), Rio de Janeiro (RJ), Brazil

  • 5Articles
  • 73.2KReads
  • 2022–2026Active
  • 19Collaborators
  • 9Citations

About

Antonio E. Nardi, MD, PhD, is affiliated with the Treatment-Resistant Depression Outpatient Clinic at the Institute of Psychiatry, Federal University of Rio de Janeiro, Brazil. His publications from 2022 to 2026 focus on treatment-resistant depression, including its operational definitions and associated impairments such as sexual desire. He has also contributed to research on psychotherapy approaches, particularly cognitive-behavioral therapy for conflict mediation, and the evaluation of long-term benzodiazepine treatment. His work is frequently co-authored with Carl Salzman, Edward Silberman, Giovanni A. Fava, Nicoletta Sonino, and Richard Balon, and published in Psychiatrist.com.

Publications

JCP
Psychotherapy and the Operational Definition of Treatment-Resistant Depression
Letter to the Editor

Psychotherapy and the Operational Definition of Treatment-Resistant Depression

August 19, 2026

Discusses recent consensus-based recommendations from Marques et al on treatment selection for treatment-resistant depression.
, ,
PCC
Conflict Mediation by CBT
Original Research

Conflict Mediation by CBT

June 26, 2025

This study tested the effectiveness of the want/can/must strategy to mediate conflicts, in which the psychotherapist, a specialist in cognitive-behavioral therapy, acts as a facilitator.
, ,
JCP
Concerns About Long-Term Benzodiazepine Treatment: Reply to Sigler et al
Letter to the Editor

Concerns About Long-Term Benzodiazepine Treatment: Reply to Sigler et al

May 27, 2024

Edward Silberman and colleagues respond to a letter about their recent commentary calling for benzodiazepine prescribing guidelines.
, , , et al
JCP
Long-Term Benzodiazepine Treatment: Toward Evidence-Based Practice Guidelines
Commentary

Long-Term Benzodiazepine Treatment: Toward Evidence-Based Practice Guidelines

October 25, 2023

The evidence about long-term benzodiazepine use presents a confounding paradox. This commentary proposes a set of prescribing guidelines for clinicians.
, , , et al
PCC
Impairment of Sexual Desire in Treatment-Resistant Depression
Original Research

Impairment of Sexual Desire in Treatment-Resistant Depression

November 22, 2022

Patients with treatment-resistant depression had a high prevalence of sexual desire impairment, which was associated with male sex and higher depressive symptom severity.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe